MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$22,357K
Net Income
-$31,683K
Net Profit Margin
-141.71%
EPS
-$0.3
Unit: Thousand (K) dollars
Revenue Breakdown
Pharma Testing Services
Population Sequencing
Clinical Diagnostic
Other
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
22,357
15,472
17,345
14,495
Cost of revenue
17,614
15,191
15,445
12,581
Research and development
16,336
14,539
13,072
12,171
Selling, general and administrative
21,998
17,903
14,094
13,034
Total costs and expenses
55,948
47,633
42,611
37,786
Loss from operations
-33,591
-32,161
-25,266
-23,291
Interest income
1,966
2,172
1,570
1,680
Interest expense
37
47
65
64
Other income (expense), net
-16
20
-42
26
Loss before income taxes
-31,678
-30,016
-23,803
-21,649
Provision for income taxes
5
16
9
3
Net loss
-31,683
-30,032
-23,812
-21,652
Basic EPS
-0.3
-0.29
-0.258
-0.24
Diluted EPS
-0.3
-0.29
-0.258
-0.24
Basic Average Shares
105,424,708
104,191,862
92,281,226
88,699,131
Diluted Average Shares
105,424,708
104,191,862
92,281,226
88,699,131
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$31,683K
(-57.97%↓ Y/Y)
Loss before income
taxes
-$31,678K
(-57.96%↓ Y/Y)
Provision for income taxes
$5K
(150.00%↑ Y/Y)
Interest income
$1,966K
(4.69%↑ Y/Y)
Pharma Testing
Services
$16,789K
Population Sequencing
$3,000K
(-9.31%↓ Y/Y)
Clinical Diagnostic
$2,541K
(441.79%↑ Y/Y)
Other
$27K
(-69.32%↓ Y/Y)
Loss from operations
-$33,591K
(-54.06%↓ Y/Y)
Revenue
$22,357K
(29.96%↑ Y/Y)
Interest expense
$37K
(-22.92%↓ Y/Y)
Other income
(expense), net
-$16K
(80.00%↑ Y/Y)
Total costs and
expenses
$55,948K
(43.43%↑ Y/Y)
Selling, general and
administrative
$21,998K
(55.14%↑ Y/Y)
Cost of revenue
$17,614K
(41.51%↑ Y/Y)
Research and development
$16,336K
(31.94%↑ Y/Y)
Buy us a coffee
Personalis, Inc. (PSNL)
Personalis, Inc. (PSNL)